[go: up one dir, main page]

MXPA02008870A - Novedosos antagonistas de lhrh, produccion de los mismos y sus uso como medicamentos. - Google Patents

Novedosos antagonistas de lhrh, produccion de los mismos y sus uso como medicamentos.

Info

Publication number
MXPA02008870A
MXPA02008870A MXPA02008870A MXPA02008870A MXPA02008870A MX PA02008870 A MXPA02008870 A MX PA02008870A MX PA02008870 A MXPA02008870 A MX PA02008870A MX PA02008870 A MXPA02008870 A MX PA02008870A MX PA02008870 A MXPA02008870 A MX PA02008870A
Authority
MX
Mexico
Prior art keywords
medicament
production
lhrh antagonists
peptides
novel lhrh
Prior art date
Application number
MXPA02008870A
Other languages
English (en)
Inventor
Kutscher Bernhard
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/525,007 external-priority patent/US6627609B1/en
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of MXPA02008870A publication Critical patent/MXPA02008870A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se refiere a péptidos que comprenden un componente aminoácido N-metilado y cuya solubilidad en agua es mejor. Los medicamentos que contienen los peptidos de conformidad con la invencion se pueden usar para el tratamiento de tumores dependientes de las hormonas y de las enfermedades no malignas en que influyen las hormonas.
MXPA02008870A 2000-03-14 2001-03-12 Novedosos antagonistas de lhrh, produccion de los mismos y sus uso como medicamentos. MXPA02008870A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/525,007 US6627609B1 (en) 1999-03-17 2000-03-14 LHRH antagonists having improved solubility properties
PCT/EP2001/002719 WO2001068676A2 (de) 2000-03-14 2001-03-12 Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel

Publications (1)

Publication Number Publication Date
MXPA02008870A true MXPA02008870A (es) 2003-06-24

Family

ID=24091545

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02008870A MXPA02008870A (es) 2000-03-14 2001-03-12 Novedosos antagonistas de lhrh, produccion de los mismos y sus uso como medicamentos.

Country Status (25)

Country Link
EP (1) EP1268522B1 (es)
JP (1) JP3805679B2 (es)
KR (1) KR100607396B1 (es)
CN (2) CN100500692C (es)
AT (1) ATE408619T1 (es)
AU (2) AU6011001A (es)
BG (1) BG107121A (es)
BR (1) BR0109279A (es)
CA (1) CA2402193C (es)
DE (1) DE50114335D1 (es)
DK (1) DK1268522T3 (es)
ES (1) ES2312435T3 (es)
HR (1) HRP20020810A2 (es)
HU (1) HUP0300222A3 (es)
IL (1) IL151647A0 (es)
MX (1) MXPA02008870A (es)
NO (1) NO20024363L (es)
NZ (1) NZ521273A (es)
PL (1) PL357999A1 (es)
PT (1) PT1268522E (es)
RU (1) RU2248982C9 (es)
SK (1) SK14332002A3 (es)
UA (1) UA79070C2 (es)
WO (1) WO2001068676A2 (es)
ZA (1) ZA200207248B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100340572C (zh) * 2004-12-01 2007-10-03 中国人民解放军军事医学科学院毒物药物研究所 新的lhrh拮抗剂
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
WO2009094634A1 (en) 2008-01-24 2009-07-30 Esperance Pharmaceuticals Lytic domain fusion constructs and methods of making and using same
TWI539959B (zh) * 2008-02-11 2016-07-01 菲瑞茵國際中心股份有限公司 治療轉移階段攝護腺癌的方法
CN101597321B (zh) * 2008-06-03 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
WO2010142060A1 (zh) * 2009-06-11 2010-12-16 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
AU2013337926B2 (en) 2012-10-30 2017-12-21 Esperance Pharmaceuticals, Inc. Antibody/drug conjugates and methods of use
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途
FR3024612B1 (fr) * 2014-08-04 2018-03-09 Alstom Transp Tech Module d'alimentation electrique d'un bloc moteur, systeme de traction et vehicule electrique associe
RU2585367C1 (ru) * 2014-11-05 2016-05-27 Наталья Владимировна Спиридонова Способ лечения бесплодия у женщин с миомой матки

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA862570B (en) * 1985-04-09 1986-12-30 Univ Tulane Therapeutic decapeptides
US5140009A (en) 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
IL101074A (en) 1991-03-14 1997-09-30 Salk Inst For Biological Studi GnRH ANALOGS AND THEIR PREPARATION
EP0593491B1 (en) 1991-04-25 1996-10-23 DEGHENGHI, Romano Luteinizing hormone releasing hormone antagonist peptides
RU2043362C1 (ru) * 1991-08-12 1995-09-10 Синтекс (Ю-Эс-Эй) Инк. Способ твердофазного синтеза пептидов
CA2136078A1 (en) 1992-12-04 1994-06-23 Jonathan Greer 6-position modified decapeptide lhrh antagonists
DK0683792T3 (da) 1992-12-18 2002-01-14 Abbott Lab LHRH-antagonister med modificerede aminoacylrester i stilling 5 og 6
IL108509A0 (en) 1993-02-22 1994-05-30 Salk Inst For Biological Studi GnRH antagonist peptides
DE4320201A1 (de) * 1993-06-18 1995-01-12 Asta Medica Ag Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
AU2001260110B2 (en) 2005-05-05
SK14332002A3 (sk) 2003-09-11
IL151647A0 (en) 2003-04-10
HUP0300222A2 (hu) 2003-07-28
ATE408619T1 (de) 2008-10-15
UA79070C2 (en) 2007-05-25
PT1268522E (pt) 2008-12-22
ES2312435T3 (es) 2009-03-01
HRP20020810A2 (en) 2004-12-31
KR20020083179A (ko) 2002-11-01
JP3805679B2 (ja) 2006-08-02
EP1268522B1 (de) 2008-09-17
HUP0300222A3 (en) 2004-08-30
AU6011001A (en) 2001-09-24
WO2001068676A2 (de) 2001-09-20
KR100607396B1 (ko) 2006-08-02
JP2003535044A (ja) 2003-11-25
NZ521273A (en) 2005-01-28
RU2248982C9 (ru) 2005-06-10
RU2248982C2 (ru) 2005-03-27
DE50114335D1 (de) 2008-10-30
EP1268522A2 (de) 2003-01-02
CN100500692C (zh) 2009-06-17
BG107121A (bg) 2003-05-30
CN1443195A (zh) 2003-09-17
PL357999A1 (en) 2004-08-09
NO20024363D0 (no) 2002-09-12
ZA200207248B (en) 2003-02-21
WO2001068676A3 (de) 2002-10-24
DK1268522T3 (da) 2009-01-12
CN1876677A (zh) 2006-12-13
CA2402193C (en) 2010-05-18
NO20024363L (no) 2002-11-13
BR0109279A (pt) 2002-12-17
CA2402193A1 (en) 2002-09-09

Similar Documents

Publication Publication Date Title
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
SE0100568D0 (sv) Compounds
HUP0301046A3 (en) Quinazoline derivatives for the treatment of tumours, process for their preparation and pharmaceutical compositions containing them
MXPA02011288A (es) Tioacetamidas substituidas.
SE0001899D0 (sv) New compounds
IL153297A0 (en) Compounds and compositions for delivering active agents
IL173348A (en) Thienopyridine compounds, pharmaceuticals containing them and their use in the preparation of drugs
HUP0204399A3 (en) Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
MY139203A (en) Pharmaceutical composition
SE0100566D0 (sv) Compounds
MXPA02008870A (es) Novedosos antagonistas de lhrh, produccion de los mismos y sus uso como medicamentos.
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
PL368686A1 (en) Novel aminobenzoephenones
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
WO2002092565A3 (en) 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
MD1473G2 (ro) Remediu antiherpetic
GB0128071D0 (en) Medicament
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration